The relationship between obesity and transforming growth factor beta on renal damage in essential hypertension

International Heart Journal

Volumn 48, Issue 6, 2007, Pages 733-741

  Torun, Dilek ^a   Ozelsancak, Ruya ^a   Turan, Inci ^a   Micozkadioglu, Hasan ^a   Sezer, Siren ^a   Ozdemir, Fatma Nurhan ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Essential hypertension; Obesity; Renal damage; Transforming growth factor beta

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; LIPID; TRANSFORMING GROWTH FACTOR BETA1; URIC ACID;

ADULT; ALBUMINURIA; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ADULT; ALBUMINURIA; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CREATININE; FEMALE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; LIPIDS; MALE; MIDDLE AGED; OBESITY; TRANSFORMING GROWTH FACTOR BETA1; URIC ACID;

EID: 37749051914     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.733     Document Type: Article

References (30)

1. Schwartz GL, Strong CG. Renal parenchymal involvement in essential hypertension. Med Clin North Am 1987; 71: 843-58.
2. Pemeger TV, Klag MJ, Feldman HI, Whelton PK. Projections of hypertension-related renal disease in middle-aged residents of the United States. JAMA 1993; 269: 1272-7.
3. Whelton PK, Klag MJ. Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence. Hypertension 1989; 13:119-27.
4. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342: 1350-8.
5. Scaglione R, Argano C, Parrinello G, et al. Relationship between transforming growth factor beta1 and progression of hypertensive renal disease. J Hum Hypertens 2002; 16: 641-5.
6. Derhaschnig U, Shehata M, Herkner H, et al. Increased levels of transforming growth factor-beta1 in essential hypertension. Am J Hypertens 2002; 15: 207-11.
7. Laviades C, Varo N, Diez J. Transforming growth factor beta in hypertensives with cardiorenal damage. Hypertension 2000; 36: 517-22.
8. Hall JE, Brands MW, Henegar JR, Shek EW. Abnormal kidney function as a cause and a consequence of obesity hypertension. Clin Exp Pharmacol Physiol 1998; 25: 58-64.
9. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL; PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 2002; 26 Suppl 4: 21-4.
10. Porreca E, Di Febbo C, Vitacolonna E, et al. Transforming growth factor-betal levels in hypertensive patients: association with body mass index and leptin. Am J Hypertens 2002; 15: 759-65.
11. Chobanian AV, Bakris GL, Black HF, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
13. Hsu CY. Does non-malignant hypertension cause renal insufficiency? Evidence-based perspective. Curr Opin Nephrol Hypertens 2002; 11: 267-72.
14. Ruilope LM, Alcazar JM, Rodicio JL. Renal consequences of arterial hypertension. J Hypertens Suppl 1992; 10: 85-90.
15. Dahly AJ, Hoagland KM, Flasch AK, Jha S, Ledbetter SR, Roman RJ. Antihypertensive effects of chronic anti-TGF-beta antibody therapy in Dahl S rats. Am J Physiol Regul Integr Comp Physiol 2002; 283: R757-67.
16. Porreca E, Di Febbo C, Mincione G, et al. Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. Hypertension 1997; 30: 134-9.
17. Border WA, Noble NA. Interactions of trainsforming growth factor-β and angiotensin II in renal fibrosis. Hypertension 1998; 31: 181-8.
18. Kurihara H, Yoshizumi M, Sugiyama T, et al. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 1989; 159: 1435-40.
19. Mikhail N, Golub MS, Tuck ML. Obesity and hypertension. Prog Cardiovasc Dis 1999; 42:39-58.
20. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 1983; 67: 968-77.
21. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974, 81: 440-7.
22. Kasiske BL, Napier J. Glomerular sclerosis in patients with massive obesity. Am J Nephrol 1985; 5: 45-50.
23. Reisin E, Messerli FG, Ventura HO, Frohlich ED. Renal haemodynamic studies in obesity hypertension. J Hypertens 1987; 5: 397-400.
24. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity induced hypertension. Renal function and systemic hemodynamics. Hypertension 1993; 22: 292-9.
25. Bosma RJ, Krikken JA, Homan van der Heide JJ, de Jong PE, Navis GJ. Obesity and renal hemodynamics. Contrib Nephrol 2006; 151: 184-202.
26. Bruzzi I, Benigni A, Remuzzi G. Role of increased glomerular protein traffic in the progression of renal failure. Kidney Int Suppl 1997; 62:29-31.
27. Derhaschnig U, Shehata M, Herkner H, et al. Increased levels of transforming growth factor-beta1 in essential hypertension. Am J Hypertens 2002; 15: 207-11.
28. Samad F, Yamamoto Y, Pandey M, Loskutoff DJ. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol Med 1997; 3: 37-48.
29. Fain JN, Tichansky DS, Madan AK. Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity. Metabolism 2005; 54: 1546-51.
30. Scaglione R, Argano C, di Chiara T, et al. Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor betal and urinary albumin excretion. Blood Press 2003; 12: 269-76.